Connor, Clark & Lunn Investment Management (CC&L)’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Buy
1,058,397
+403,698
+62% +$960K 0.01% 926
2025
Q4
$1.59M Buy
654,699
+523,064
+397% +$1.85M ﹤0.01% 993
2025
Q3
$499K Buy
+131,635
New +$385K ﹤0.01% 1259
2025
Q1
Sell
-246,681
Closed -$528K 1406
2024
Q4
$528K Sell
246,681
-37,472
-13% -$107K ﹤0.01% 1129
2024
Q3
$1.24M Sell
284,153
-2,693
-0.9% -$14.7K 0.01% 815
2024
Q2
$1.34M Sell
286,846
-27,656
-9% -$148K 0.01% 778
2024
Q1
$1.59M Buy
+314,502
New +$1.27M 0.01% 735
2022
Q4
Sell
-82,881
Closed -$140K 1210
2022
Q3
$140K Buy
82,881
+70,551
+572% +$218K ﹤0.01% 1025
2022
Q2
$30K Buy
+12,330
New +$28.7K ﹤0.01% 1015

Other funds holding BDTX